uploads/2017/01/Monsanto-Analysts-NTM-Recommendation-2017-01-24-1.jpg

Monsanto: Analyst Recommendations and Price Target

By

Updated

About Monsanto

Monsanto (MON) seems to be everywhere in our day-to-day lives, from the food we eat to the gas in the cars we drive. To learn more about Monsanto, read An In-Depth Review of Monsanto Company’s 2016.

On January 5, 2017, Monsanto announced its fiscal 1Q17 earnings. The quarter ended November 30, 2016. After the earnings release, Monsanto stock barely moved, closing the day at $105.21.

Analyst recommendations

Of the 18 Wall Street analysts covering Monsanto, three of them have given the stock a “strong buy,” and eight have given it a “buy” for the next 12 months. Seven analysts have recommended a “hold,” and none of them have given it a “sell” or a “strong sell” for the same period.

Last year, Monsanto agreed to a buyout offer from Bayer priced at $128 per share. However, Monsanto stock continues to trade below that price. Investors seem doubtful that the deal will get through antitrust regulators.

Price target

Wall Street analysts have a next 12-month price target of $119.80 per share for Monsanto stock. On January 23, 2017, Monsanto closed at $108.40. That was 3.0% higher than the company’s recent 1Q17 earnings release, but it was still about 10.0% below analysts’ price target. That wasn’t the case for fertilizer companies (SOIL) such as PotashCorp (POT), Mosaic (MOS), and CF Industries (CF).

Next, we’ll take a look at FMC (FMC).

More From Market Realist